Koios Beverage (CSE:KBEV, OTC:SNOVF) (the “Company” or “Koios”), is pleased to announce that the Company has increased its production capacity by partnering with Full Metal Canning, located in Longmont, CO, in addition to its current partnership with Golden Global Goods, the parent company of Rocky Mountain Soda.
The new partnership grants the Company access to Full Metal Canning’s high-volume production line, ensuring the functional beverage manufacturer can produce a lower minimum amount of product at any given time, while simultaneously achieving the same cost-effectiveness which could otherwise be gained through mass production.
The partnerships with Full Metal Canning and Golden Global Goods will provide the Company with the available use of two canning lines in their local Colorado market. This not only allows Koios to produce twice the amount of product but it also provides for a much more rapid pace at which orders are fulfilled.
Forming these partnerships came as a result of the Company securing purchase orders with two of the largest retailers in the world, thereby increasing its retail footprint by 4,000 locations since February 2019. Chris Miller, Founder, and CEO of Koios further explains, “This allows us to stay incredibly adept and flexible when producing our line of beverages. This advantage makes us especially unique in the beverage space as we can produce on demand without investing large sums of capital into excess inventory. This allows our team to increase its focus on marketing and consumer awareness, which is pivotal in a brand’s success. Furthermore, the relationship with Full Metal Canning is a monumental first step towards investing in further infrastructure, including our own, wholly-owned canning line.”
With the new Full Metal Canning partnership in addition to our existing partnership with Golden Global Goods, the Company can now produce up to 15,000 cases per week; moreover, this rate of production allows for the following:
- Reduced lead times;
- Reduced upfront costs;
- Creates added efficiency in COGS (Cost of Goods Sold);
- Greater control over the production process; and
- Warrants the Company to fine-tune and adjust flavors as needed.
With the recent addition of purchase orders from two of the largest retailers in the world, the Company further acknowledges the significance of on-demand production. Also, the additional canning line generates pliancy in production for the projected release of the Company’s Fit Soda™ line in Q3 of 2019.
On behalf of the Board of Directors of the Company.
KOIOS BEVERAGE CORP.
Chris Miller, CEO, and Director
About Koios Beverage Corp.
The Company is an emerging functional beverage company which has an available distribution network of more than 5,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing CBD market. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com.
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: that the Company intends to increase its production capacity by partnering with Full Metal Canning; statements with respect to the perceived potential benefits of the partnership with Full Metal Canning, including but not limited to: cost-effectiveness, efficiency, volume of production, ability to produce on demand, control over the production process and timing of production and fulfillment of orders; that the partnership with Full Metal Canning will allow Koios to increase its focus on marketing and consumer awareness; that the partnership with Full Metal Canning is a first step towards investing in further infrastructure; statements with respect to the growth and size of the functional beverage market; and statements regarding the business of the Company. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include: adverse market conditions; changes to the growth and size of the functional beverage market; consumer acceptance and adoption of functional beverages as compared to other beverages and the possibility consumers may not embrace functional beverages as expected or at all; the extent to which the Company is successful in gaining new long-term relationships with new retailers and retaining existing relationships with retailers; the fact that the Company does not own or operate any of its production facilities and that co-packers may not renew current agreements and/or not satisfy increased production quotas; the potential for supply chain interruption due to factors beyond the Company’s control; the possibility that there may be a recall of products due to unintended contamination; competition in the industry in which the Company operates; the Company’s ability to raise the additional funding that it may need to continue to pursue its business; and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.
For further information: Gina Burrus, 844-255-6467, firstname.lastname@example.org
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or